Azerbaijan vs Myanmar: Previously treated cases tested for RR-/MDR-TB
Azerbaijan
94.0%
in 2024
Myanmar
94.0%
in 2024
Azerbaijan rank
72nd
Myanmar rank
72nd
Previously treated cases tested for RR-/MDR-TB over time
- Azerbaijan
- Myanmar
How they compare
Azerbaijan currently reports 94.0% against 94.0% in Myanmar, a difference of 0.0%.
The two have swapped places 5 times across 13 shared years of data; in 2006 it was Azerbaijan ahead.
Azerbaijan ranks 72nd and Myanmar ranks 72nd of 180 countries.
Azerbaijan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.0% | 9.4% | 2.6% | Azerbaijan |
| 2010s | 76.4% | 64.1% | 12.3% | Azerbaijan |
| 2020s | 98.0% | 92.8% | 5.2% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Azerbaijan or Myanmar?
- Azerbaijan, at 94.0% against 94.0% in Myanmar as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Azerbaijan and Myanmar?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Myanmar?
- 13 years are reported by both, from 2006 to 2024.
- How do Azerbaijan and Myanmar rank globally for previously treated cases tested for rr-/mdr-tb?
- Azerbaijan ranks 72nd and Myanmar ranks 72nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.